The Recombinant Antibody Network (RAN), a consortium comprising research groups from UC San Francisco, the University of Chicago, and the University of Toronto, has entered into a second research collaboration with Celgene that aims to create and develop high-performance recombinant antibodies against diverse targets in human cells. The first RAN collaboration was launched in 2015 […]
Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, has announced a partnership with the Recombinant Antibody Network (RAN), a consortium of three expert centers at the University of Chicago, University of Toronto, and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies at a proteome-wide scale. Under the
The RAN has recently signed a 3-year $25M agreement with the Celgene Corporation to develop next-generation, antibody-based cancer therapies with the option to enter into future license agreements. Collaboration will focus on novel high value cancer targets. Besides supporting the high throughput antibody generating pipelines, this agreement will enable setting up robotics for a battery of state
RAN to collaborate with Celgene on cancer therapeutics development Read More »
We have established a collection ‘IP gold standard’ antibodies in the tour de force study of 1,124 new recombinant antibodies for 152 chromatin-related human proteins. This set is accomapnied with a collection of SOPs which can be accesed here rdcu.be/dfUd.
‘IP gold standard’ antibodies for select chromatin-related human proteins developed Read More »
We have recently updated the antibody catalog with new antibody binders that are made available by the Recombinant Antibody Network. There are currently 852 binders available in the catalog.
852 rAbs in our catalog! Read More »
We have recently updated the antibody catalog with new antibody binders that are made available by the Recombinant Antibody Network. There are currently 495 binders available in the catalog.
New binders added to antibody catalog Read More »
Advanced robotic system designed to screen thousands of recombinant antibodies without human intervention. Video shows sequence of ELISA and colony picking schedules executed on the same system. Portions of this video has been speed up by a factor of 2.
Automated antibody phage display selection and screening system Read More »
In December 2012 the UCSF node of the RAN received funding from the California Instituet for Quantitative Biosciences (QB3) to kickstart the development of two automated protein expression pipelines designed to suppliment the RAN antigen needs.
UCSF RAN Node Receives QB3 funds to explore alternative protein expression platforms Read More »
A major strength of the management structure is the proven record of the leadership to work in unison to manage large, complex and intellectually challenging programs. In fact, several of the team have successfully managed projects in industry that were significantly larger and more complex than what is proposed here. Further, the RAN leadership team
RAN: A proven track record for collaboration Read More »
